Aurobindo gets USFDA nod for it's anti-depressant

Mumbai, Sept 12 (UNI) Aurobindo Pharma today announced that they have received the US Food and Drug Authority's approval for its product 'Citalopram', in the oral solution form, which is used in the treatment of depressive disorders.

Announcing this to the Bombay Stock Exchange, the company said it already has approval of 'Citalopram' tablets of 10, 20, and 40mg strengths.

UNI SN WD VKG1920